Glyn Edwards is the founder of Summit Therapeutics. Summit Therapeutics has raised $50M in total funding. Latest round: Growth. Backed by Akeso, Inc..
Glyn Edwards is the CEO of Summit Therapeutics, a drug discovery and development company. The company focuses on advancing therapies for Duchenne muscular dystrophy (DMD) and C. difficile infection (CDI). Summit Therapeutics has secured a US$50 million funding deal with biotech billionaire Bob Duggan.
Full founder directory · Investor directory · Company funding database · Fundraising library